Literature DB >> 27277484

Detection of hepatocellular carcinoma capsule by contrast-enhanced ultrasound using Levovist: correlations with pathological findings.

Pabitra K Bhattacharjee1, Akiko Saito2, Michiyo Chiba1, Hideo Katsuragawa1, Ken Takasaki1.   

Abstract

PURPOSE: To determine the most appropriate therapy for each hepatocellular carcinoma (HCC) nodule, it is important to ascertain whether the tumor has a capsule. The aim of this study was to investigate the diagnostic potential of contrast-enhanced ultrasound (CEUS) in HCC capsule detection by comparing ultrasound findings with histological results from operative specimens.
METHODS: Thirty-six HCC nodules (all smaller than 5 cm) from 36 patients who had undergone hepatectomy were examined by CEUS using Levovist with agent detection imaging. The vascular phase images and time course changes of HCC were observed after a bolus injection of Levovist. We classified the appearance of the tumor artery, tumor enhancement, and washout into several patterns. We grouped HCCs into encapsulated or nonencapsulated on the basis of the histology of the operative specimens, taking into account the effectiveness of transcatheter arterial chemoembolization. Ultrasound and pathological findings were compared to assess the ability of CEUS to detect HCC capsules.
RESULTS: During the arterial phase, 12 (80.0%) encapsulated and 3 (14.3%) nonencapsulated HCC nodules showed a surrounding artery with branches pattern (P < 0.0001). The sensitivity, specificity, and accuracy of this pattern for HCC capsule detection were 80%, 86%, and 83%, respectively. A branching artery was found in 15 (71.4%) nonencapsulated but in only 3 (20.0%) encapsulated HCC nodules (P < 0.01). The sensitivity, specificity, and accuracy of this branching artery pattern for confirming the absence of a capsule in HCC nodules were 71%, 80%, and 75%, respectively. Almost all HCC nodules showed strong-moderate or weak enhancement and strong-moderate or mild washout. Neither enhancement nor washout pattern correlated with the presence of a capsule.
CONCLUSION: The arterial phase of CEUS is very useful for detection of HCC capsules and therefore facilitates selection of the most appropriate treatment method for HCC.

Entities:  

Keywords:  Levovist; capsule formation; contrast media; contrast-enhanced ultrasonography; hepatocellular carcinoma

Year:  2005        PMID: 27277484     DOI: 10.1007/s10396-005-0069-4

Source DB:  PubMed          Journal:  J Med Ultrason (2001)        ISSN: 1346-4523            Impact factor:   1.314


  12 in total

1.  Characterization of focal liver lesions in real time using harmonic imaging with high mechanical index and contrast agent levovist.

Authors:  V Migaleddu; G Virgilio; D Turilli; M Conti; G Campisi; N Canu; D Sirigu; I Vincentelli
Journal:  AJR Am J Roentgenol       Date:  2004-06       Impact factor: 3.959

2.  Classification of ultrasonographic images of small hepatocellular carcinoma using galactose-based contrast agent: relation between image patterns and histologic features.

Authors:  Yasuo Matsuda; Iwao Yabuuchi; Toshikazu Ito; Ryoichi Arima
Journal:  J Med Ultrason (2001)       Date:  2004-09       Impact factor: 1.314

3.  Contrast-enhanced agent detection imaging: Early experience in hepatocellular carcinoma.

Authors:  Yan Ling Wen; Masatoshi Kudo; Yasunori Minami; Hobyung Chung; Yoichiro Suetomi; Hirokazu Onda; Masayuki Kitano; Toshihiko Kawasaki; Kiyoshi Maekawa
Journal:  J Med Ultrason (2001)       Date:  2003-06       Impact factor: 1.314

4.  An appraisal of transcatheter arterial embolization combined with transcatheter arterial infusion of chemotherapeutic agent for hepatic malignancies.

Authors:  J Okamura; S Horikawa; T Fujiyama; M Monden; J Kambayashi; O Sikujara; M Sakurai; C Kuroda; H Nakamura; G Kosaki
Journal:  World J Surg       Date:  1982-05       Impact factor: 3.352

5.  Dynamic sonography of hepatic tumors.

Authors:  S Tanaka; T Ioka; O Oshikawa; Y Hamada; F Yoshioka
Journal:  AJR Am J Roentgenol       Date:  2001-10       Impact factor: 3.959

6.  Pathological evaluation of hepatic dearterialization in encapsulated hepatocellular carcinoma.

Authors:  N Tanaka; E Okamoto; A Toyosaka; S Fujiwara
Journal:  J Surg Oncol       Date:  1985-08       Impact factor: 3.454

7.  Diagnosis of small hepatocellular carcinoma: correlation of MR imaging and tumor histologic studies.

Authors:  M Ebara; M Ohto; Y Watanabe; K Kimura; H Saisho; Y Tsuchiya; K Okuda; N Arimizu; F Kondo; H Ikehira
Journal:  Radiology       Date:  1986-05       Impact factor: 11.105

8.  Contrast enhancement patterns of hepatic tumours during the vascular phase using coded harmonic imaging and Levovist to differentiate hepatocellular carcinoma from other focal lesions.

Authors:  J Furuse; M Nagase; H Ishii; M Yoshino
Journal:  Br J Radiol       Date:  2003-06       Impact factor: 3.039

9.  Tumor encapsulation in hepatocellular carcinoma. A pathologic study of 189 cases.

Authors:  I O Ng; E C Lai; M M Ng; S T Fan
Journal:  Cancer       Date:  1992-07-01       Impact factor: 6.860

10.  Vascular supply in adenomatous hyperplasia of the liver and hepatocellular carcinoma: a morphometric study.

Authors:  K Ueda; T Terada; Y Nakanuma; O Matsui
Journal:  Hum Pathol       Date:  1992-06       Impact factor: 3.466

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.